舌下神经刺激治疗阻塞性睡眠呼吸暂停的评估
该研究汇总3项前瞻性队列和1项回顾性队列共584例无法耐受持续气道正压通气的中重度阻塞性睡眠呼吸暂停成人,评估舌下神经刺激与疾病严重度、日间嗜睡及睡眠相关生活质量的关系,发现术后AHI、嗜睡及生活质量均有临床显著改善,年龄、BMI和术前AHI与疗效相关。
要点
- 舌下神经刺激可显著改善中重度OSA患者的AHI、日间嗜睡及睡眠相关生活质量。
- 术前AHI更高、年龄更大、BMI更低的患者术后AHI改善更明显。
- 调整相关变量后,12个月时AHI较6个月时统计学上更高。
核心结论
- 舌下神经刺激在此汇总队列中显示出对OSA严重度、日间嗜睡和睡眠相关生活质量的临床显著改善。
- 年龄、BMI和术前AHI似乎与治疗结局相关,可能部分解释2至6个月与12个月结局的差异。
研究设计与样本
- 患者水平数据汇总自3项前瞻性队列和1项回顾性观察队列,共584例无法耐受或获益于持续气道正压通气的中重度OSA成人。
- 数据来源包括STAR试验、德国上市后研究、国际ADHERE注册研究和美国2个中心的回顾性队列研究。
主要发现
- 584例中男性472例(80.8%),平均(SD)年龄58.5(11.0)岁。
- 术后AHI改善更大与术前AHI更高(-0.74 events/h;95% CI,-0.82至-0.67)、年龄更大(-0.10 events/h;95% CI,-0.20至-0.00)和BMI更低(0.52;95% CI,0.22-0.83)相关。
- 调整上述变量并考虑所有患者后,12个月时AHI在统计学上高于6个月时(3.24 events/h;95% CI,1.67-4.82 events/h)。
临床怎么用
- 对于无法耐受CPAP的中重度OSA成人,舌下神经刺激可作为改善AHI、日间嗜睡和生活质量的治疗选择。
- 术前AHI较高、年龄较大和BMI较低的患者可能获得更大的AHI改善,可据此进行患者选择与咨询。
局限性
- 本研究为汇总队列分析,包含回顾性观察队列,可能存在选择偏倚和混杂。
- AHI和Epworth嗜睡量表结局在不同队列的随访时间不一致(2至6个月和/或12个月),部分结局数据仅在可获得时收集。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hypoglossal nerve stimulation is a treatment option for patients with obstructive sleep apnea unable to tolerate continuous positive airway pressure. This study evaluates demographic factors that may be associated with greater improvements in postoperative outcomes of interest. OBJECTIVE: To examine the association of hypoglossal nerve stimulation with obstructive sleep apnea severity, daytime sleepiness, and sleep-related quality of life. DESIGN, SETTING, AND PARTICIPANTS: Patient-level data were pooled from 3 prospective cohorts and 1 retrospective observational cohort comprising 584 adults with moderate to severe obstructive sleep apnea unable to tolerate or benefit from continuous positive airway pressure. The data were gathered from the Stimulation Therapy for Apnea Reduction Trial; a postmarket approval study conducted in Germany; the multicenter, international Adherence and Outcome of Upper Airway Stimulation for OSA Registry; and a retrospective cohort study from 2 sites in the United States. EXPOSURE: Hypoglossal nerve stimulation. MAIN OUTCOMES AND MEASURES: Severity of obstructive sleep apnea was the primary outcome. The apnea-hypopnea index (AHI) (<5, normal; 5-15, mild; 15-30, moderate, and >30, severe) and Epworth Sleepiness Scale (range, 0-24; score >10 indicates pathologic sleepiness) outcomes were available at 2 to 6 months from 2 cohorts (n = 398), at 12 months from 1 cohort (n = 126), and at both times from 1 cohort (n = 60). Sleep-related quality of life and oxygen saturation nadir data were collected where available. Linear mixed-effects models were constructed to examine associations between clinical variables and reported postoperative outcomes at 6 and 12 months with study included as a random effect. RESULTS: Of the 584 patients included in the study, 472 were men (80.8%); mean (SD) age was 58.5 (11.0) years. Greater improvement in the postoperative AHI was associated with a higher preoperative AHI (-0.74 events/h; 95% CI, -0.82 to -0.67), older patient age (-0.10 events/h; 95% CI, -0.20 to -0.00), and lower body mass index (0.52; 95% CI, 0.22-0.83). After adjusting for these variables and considering all patients in the analysis, the AHI was statistically higher at 12 months than at 6 months (3.24 events/h; 95% CI, 1.67-4.82 events/h). CONCLUSIONS AND RELEVANCE: Hypoglossal nerve stimulation demonstrated clinically significant improvements in obstructive sleep apnea severity, daytime sleepiness, and sleep-related quality of life in this pooled cohort of patient-level results. Age, body mass index, and preoperative AHI appeared to be associated with treatment outcomes, and these variables may explain some of the difference between 2- to 6-month and 12-month outcomes.
引用
- Kent DT, Carden KA, Wang L, et al. Evaluation of Hypoglossal Nerve Stimulation Treatment in Obstructive Sleep Apnea. JAMA Otolaryngol Head Neck Surg. 2019. PMID: 31556927. doi:10.1001/jamaoto.2019.2723
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。